Due to a system-wide technology update, we are experiencing extremely high call volume. We appreciate your patience with our operators during this time. Thank you for choosing Fox Chase Cancer Center.
Elizabeth Plimack, MD, MS
- Request Appointment
- Clinical Locations
- About
- Education and Training
- Patient Stories
- Research Profile
- Publications
- Ratings
Clinical Locations
Primary Location
Fox Chase Cancer Center
333 Cottman Avenue
Philadelphia, PA 19111
About
Deputy Director, Fox Chase Cancer Center
Professor, Department of Hematology/Oncology
Director, Genitourinary Clinical Research
NCCN, Bladder/Penile Cancers Panel Member
NCCN, Kidney Cancer Panel Member
Specialties
Research Program
Key Awards
 |
| Medical Oncology |
Treatment Philosophy
With a diagnosis of cancer comes uncertainty and fear for many patients. As a medical oncologist, my first job is to help each patient understand his or her diagnosis. With that understanding, together we can design the best plan of action. At Fox Chase, each patient has the benefit of an interdisciplinary team working together to ensure the highest quality care. This interdisciplinary approach is crucial in determining and implementing the best treatment plan.
I specialize in the treatment of kidney, bladder, prostate and testicular cancer, and my clinical practice is focused on these diseases. By concentrating exclusively on genitourinary malignancies I am able to offer expert knowledge as well as access to both standard treatments and emerging therapies in the form of clinical trials. The pace of scientific discovery has accelerated in recent decades, and fortunately we have seen these discoveries translate into meaningful improvements in cancer treatments.
As part of the genitourinary group here at Fox Chase, I am proud to be a part of a team of distinguished researchers who have pioneered many of these new treatments. My particular research efforts focus on the development of new therapies for bladder and kidney cancer.
Education and Training
Educational Background
- Chief Fellow, Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX
- Intern and Resident, Internal Medicine, New York University Medical Center / Bellevue Hospital, NY
- MS, Patient-Based Biologic Research, University of Texas Graduate School of Biomedical Sciences, 2008
- MD with Honors in Pathology, New York University School of Medicine, 2002
Memberships
- National Comprehensive Cancer Network (NCCN)
- Bladder/Penile Cancers Panel
- Kidney/Testicular Cancers Panel
- Prostate Cancer Panel
- American Society of Clinical Oncology (ASCO)
- 2015-2018 — ASCO Scientific Committee, Genitourinary (non-prostate)
- 2016-2017 — Track Chair, ASCO Scientific Committee, Genitourinary (non-prostate)
- 2020-2024 — Elected Member, ASCO Board of Directors
- Bladder Cancer Advocacy Network (BCAN)
- 2013-2019 — BCAN Think Tank Steering Committee
- 2016-2017 — Co-Chair, 2017 BCAN Think Tank
- 2017-2018 — Chair, 2018 BCAN Think Tank
- 2014 — Bladder Cancer Advocacy Network Young Investigator Award Study Section
- 2015-2018 — Chair, Bladder Cancer Advocacy Network Young Investigator Award Study Section
- 2018-Present — Bladder Cancer Research Network (BCRN) Management Committee
- 2020-2023 — Chair, BCAN Scientific Advisory Board
- Department of Defense (DOD) Congressionally Directed Medical Research Programs (CDMRP) Study Section
- 2015, 2016, 2017 — Reviewer, Peer Reviewed Cancer Research Program (PRCRP), Kidney Cancer
- 2020 — Chair, Peer Reviewed Cancer Research Program (PRCRP), Kidney Cancer
- 2021 — Programmatic Panel Member. Congressionally Directed Medical Research Programs: Kidney Cancer
Honors & Awards
- Philadelphia Magazine Top Doctors, 2017-2022
- Best Doctors in America® , 2019-2020, Medical Oncology and Hematology
- America's Top Doctors®, 2017
- Leadership Forum Excellence Award, Fox Chase Cancer Center, 2012
- Humanitas Award, Division of Cancer Medicine Hematology/Oncology Fellowship, MD Anderson Cancer Center, 2008
- Award for Achievement in Clinical Investigation, Division of Cancer Medicine, MD Anderson Cancer Center, 2008
- Research Forum, MD Anderson Cancer Center, 2008
- Honorable Mention, First Annual Hematology/Oncology Fellowship Program, 2008
- ASCO Foundation Merit Award, ASCO Genitourinary Cancers Symposium, 2008
Patient Stories
Donna McAllister
Bladder Cancer
Donna McAllister
Bladder Cancer
I was treated with compassion, given hope, and kept informed of every facet of my treatment.
Al De Carlo
Kidney Cancer
Al De Carlo
Kidney Cancer
Now that I’m 74 and retired, I spend most of my time outside or in the garage. Since my service in the Navy, where I worked as a ship fitter, taking care of the plumbing and mechanical issues, I’ve always been fascinated with machines and how they work. So for me, as crazy as it seems to my wife, working outside, tinkering with machines, and splitting wood, isn’t hard work – it’s my playtime.
Ed Horowitz
Prostate Cancer
Ed Horowitz
Prostate Cancer
When Ed Horowitz was diagnosed with prostate cancer in 2008, he had to make a decision whether to undergo radiation or surgery. After receiving one opinion from a surgeon at a large Philadelphia hospital, he decided to seek a second opinion from Dr. Eric Horwitz, chair of radiation oncology at Fox Chase Cancer Center. Ed liked Dr. Horowitz's warm demeanor and sense of humor and decided to be treated with IMRT (intensity modulated radiation therapy) combined with hormone injections, followed by radiation and hormone therapy. The treatment was successful. A few years later, his cancer returned, isolated to his shoulder this time. Ed started another course of chemotherapy in March 2016. "My cancer has not grown and has not spread since I completed chemotherapy," he said. "I always recommend Fox Chase to anyone considering treatment for prostate cancer. I consider myself fortunate to have gone there for treatment."
Kevin Galligan
Kidney Cancer
Kevin Galligan
Kidney Cancer
Kevin Galligan had a respiratory infection and cough in 2012, when his doctor scheduled an X-ray which detected an issue with his right lung. Kevin was beyond frustrated when several tests he underwent by a pulmonologist were found to be inconclusive. However, after being referred to a thoracic surgeon, he was diagnosed with stage 4 renal cancer. Kevin had his right kidney and a rib removed before finding out the cancer had spread to his lung. He was then referred to Fox Chase Cancer Center, where he enrolled in a clinical trial. As a result, his tumors have continued to shrink. "Being referred to Dr. Plimack at Fox Chase was the best thing that could have happened to me," he said. "At Fox Chase, I received state-of-the-art treatment, and I have been able to easily manage the side effects of the clinical trial drugs. I remain very active and am able to work every day at an international logistics and transportation company, where I am a vice president."
Pages
Research Profile
Research Program
Research Interests
- Biomarkers predictive of response to neoadjuvant cisplatin based chemotherapy in bladder cancer
- Refining neoadjuvant chemotherapy regimens for bladder cancer
- Developmental Therapeutics – early stage clinical trials of novel agents
- Immunotherapy in GU Malignancies
Publications
Clinical Locations
Primary Location
Fox Chase Cancer Center
333 Cottman Avenue
Philadelphia, PA 19111
Deputy Director, Fox Chase Cancer Center
Professor, Department of Hematology/Oncology
Director, Genitourinary Clinical Research
NCCN, Bladder/Penile Cancers Panel Member
NCCN, Kidney Cancer Panel Member
Research Program
Key Awards
|
| Medical Oncology |
Treatment Philosophy
With a diagnosis of cancer comes uncertainty and fear for many patients. As a medical oncologist, my first job is to help each patient understand his or her diagnosis. With that understanding, together we can design the best plan of action. At Fox Chase, each patient has the benefit of an interdisciplinary team working together to ensure the highest quality care. This interdisciplinary approach is crucial in determining and implementing the best treatment plan.
I specialize in the treatment of kidney, bladder, prostate and testicular cancer, and my clinical practice is focused on these diseases. By concentrating exclusively on genitourinary malignancies I am able to offer expert knowledge as well as access to both standard treatments and emerging therapies in the form of clinical trials. The pace of scientific discovery has accelerated in recent decades, and fortunately we have seen these discoveries translate into meaningful improvements in cancer treatments.
As part of the genitourinary group here at Fox Chase, I am proud to be a part of a team of distinguished researchers who have pioneered many of these new treatments. My particular research efforts focus on the development of new therapies for bladder and kidney cancer.
Education
Educational Background
- Chief Fellow, Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX
- Intern and Resident, Internal Medicine, New York University Medical Center / Bellevue Hospital, NY
- MS, Patient-Based Biologic Research, University of Texas Graduate School of Biomedical Sciences, 2008
- MD with Honors in Pathology, New York University School of Medicine, 2002
Memberships
- National Comprehensive Cancer Network (NCCN)
- Bladder/Penile Cancers Panel
- Kidney/Testicular Cancers Panel
- Prostate Cancer Panel
- American Society of Clinical Oncology (ASCO)
- 2015-2018 — ASCO Scientific Committee, Genitourinary (non-prostate)
- 2016-2017 — Track Chair, ASCO Scientific Committee, Genitourinary (non-prostate)
- 2020-2024 — Elected Member, ASCO Board of Directors
- Bladder Cancer Advocacy Network (BCAN)
- 2013-2019 — BCAN Think Tank Steering Committee
- 2016-2017 — Co-Chair, 2017 BCAN Think Tank
- 2017-2018 — Chair, 2018 BCAN Think Tank
- 2014 — Bladder Cancer Advocacy Network Young Investigator Award Study Section
- 2015-2018 — Chair, Bladder Cancer Advocacy Network Young Investigator Award Study Section
- 2018-Present — Bladder Cancer Research Network (BCRN) Management Committee
- 2020-2023 — Chair, BCAN Scientific Advisory Board
- Department of Defense (DOD) Congressionally Directed Medical Research Programs (CDMRP) Study Section
- 2015, 2016, 2017 — Reviewer, Peer Reviewed Cancer Research Program (PRCRP), Kidney Cancer
- 2020 — Chair, Peer Reviewed Cancer Research Program (PRCRP), Kidney Cancer
- 2021 — Programmatic Panel Member. Congressionally Directed Medical Research Programs: Kidney Cancer
Honors & Awards
- Philadelphia Magazine Top Doctors, 2017-2022
- Best Doctors in America® , 2019-2020, Medical Oncology and Hematology
- America's Top Doctors®, 2017
- Leadership Forum Excellence Award, Fox Chase Cancer Center, 2012
- Humanitas Award, Division of Cancer Medicine Hematology/Oncology Fellowship, MD Anderson Cancer Center, 2008
- Award for Achievement in Clinical Investigation, Division of Cancer Medicine, MD Anderson Cancer Center, 2008
- Research Forum, MD Anderson Cancer Center, 2008
- Honorable Mention, First Annual Hematology/Oncology Fellowship Program, 2008
- ASCO Foundation Merit Award, ASCO Genitourinary Cancers Symposium, 2008
Research Profile
Research Interests
- Biomarkers predictive of response to neoadjuvant cisplatin based chemotherapy in bladder cancer
- Refining neoadjuvant chemotherapy regimens for bladder cancer
- Developmental Therapeutics – early stage clinical trials of novel agents
- Immunotherapy in GU Malignancies
Publications
Selected Publications
Additional Publications
Related Articles
25 PATIENT COMMENTS
-
5.0
June 18, 2022
Fox Chase is the best!
-
No Star Ratings Available
June 15, 2022
Awesome!!
-
5.0
June 08, 2022
I am very, very happy with my doctor and nurses, and all of the wonderful care that I have received at Fox Chase. I have every confidence in them.
-
5.0
June 03, 2022
All good, thank you.
-
5.0
May 14, 2022
Professional Efficient
-
5.0
April 02, 2022
Everyone at Fox Chase was super. Very caring.
-
5.0
March 22, 2022
Dr. Plimack is spectacular.
-
No Star Ratings Available
March 14, 2022
Again, Fox Chase .. Best hospital in the world
-
No Star Ratings Available
February 28, 2022
Exceptional listener and always answers my questions.
-
5.0
February 21, 2022
Everyone at Fox Chase makes me feel like a valued human being and sincerely concerned with treatment.
-
5.0
January 04, 2022
My experience with Dr. Plimack could not be better. She is the reason my cancer is under control.
-
5.0
November 16, 2021
I am impressed with the attention and care that I am receiving.
-
5.0
November 13, 2021
Dr. Plimack is the reason I am still alive. I am very thankful for her treatment & care towards me.
-
5.0
October 08, 2021
Dr. Plum Mack as consistently shown nothing but care and concern for my well being and treatment since she took over for [...] when he retired. I can not conceive of receiving better care. This visit was my 10 year clean anniversary and my last visit as Dr. Plimmack discharged me. She reassured me that, if at any time, I felt the need to contact her she would make herself available. I recommend her highly.
-
No Star Ratings Available
September 30, 2021
Very kind and patient
-
5.0
September 20, 2021
You could never find a doctor better than Dr. Plimack.
-
5.0
September 15, 2021
I saw Dr. Plimack for a second opinion. The visit with her was excellent. She was very professional, upbeat and clearly explained my treatment options, while addressing all my concerns.
-
5.0
August 28, 2021
Awesome as always
-
No Star Ratings Available
July 30, 2021
Good experience
-
5.0
July 27, 2021
We love Dr. Plimack!!
LOAD MORE